In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

Panelists discuss that improving outcomes for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) requires multifaceted efforts including developing ...

The UAB researchers showed that TREM2 — which stands for triggering receptors expressed on myeloid cells 2 — is predominantly ...

Background: Low bone mineral density (BMD) is recognised in individuals with cystic fibrosis (CF) although the pathogenesis remains unclear. The aims of this study were to compare BMD over a broad ...

Discover how cystic fibrosis genetics affect inheritance patterns and symptom. Learn about CFTR mutations, testing options, and emerging genetic therapies.

Cutting-edge treatments offer new hope for those living with cystic fibrosis Decades of clinical trials have drastically improved both life expectancy and quality of life for those with cystic ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of hereditary amyloidosis.

Learn how to navigate cystic fibrosis care with confidence, from treatments and school plans to building a supportive medical team.

About the Cystic Fibrosis Trust Cystic Fibrosis Trust is the only UK-wide charity dedicated to uniting for a life unlimited for everyone affected by cystic fibrosis. The Trust funds cutting edge ...

The UK Cystic Fibrosis Gene Therapy Consortium (GTC) comprises researchers from Imperial College London and the Universities of Oxford and Edinburgh. In 2001, the groups joined together as one ...

Here's what cystic fibrosis is, what causes it and how it's usually treated once it has been diagnosed.